Zifan Gong
About Zifan Gong
Zifan Gong is a Principal Scientist at Bristol Myers Squibb with extensive experience in drug product technologies and commercial product development.
Current Role at Bristol Myers Squibb
Zifan Gong is currently serving as a Principal Scientist at Bristol Myers Squibb, working within the Parenteral Manufacturing Science and Technology (MS&T) division. This position is based in New Brunswick, New Jersey, and involves a hybrid work model. In this role, Gong contributes to the development and oversight of parenteral drug products, leveraging his extensive background in pharmaceutical engineering and drug product technologies.
Previous Experience at Incyte
Zifan Gong previously held the position of Senior Research Investigator in Drug Product Technologies at Incyte. His tenure at Incyte lasted from 2022 to 2024, where he worked in Wilmington, Delaware. During this period, Gong was involved in various aspects of drug product development, focusing on the transition of drugs from initial stages to final commercial products.
Education and Academic Background
Zifan Gong earned his Doctor of Philosophy (Ph.D.) in Chemical and Biomolecular Engineering from the University of Maryland, where he studied from 2012 to 2017. Prior to that, he completed his Bachelor's Degree in Pharmaceutical Engineering at Tianjin University, studying from 2008 to 2012. His academic training has provided him with a strong foundation in chemical engineering principles and their application in pharmaceutical product development.
Specialization and Expertise
Zifan Gong has deep expertise in developing pediatric and device-integrated/combination products. He specializes in program delivery, submission review, and approval for late-stage and commercial products. Additionally, Gong is well-versed in managing commercial product lifecycle through prior approval supplements (PAS). His proficiency extends to QbD risk assessment, FMEA, process validation, and product control strategy, making him a valuable asset in ensuring product quality and compliance.
Professional Contributions
Throughout his career, Zifan Gong has demonstrated a strong ability to manage external vendors, including Contract Development and Manufacturing Organizations (CDMOs) and Contract Research Organizations (CROs). This expertise supports end-to-end drug product manufacturing, ensuring all processes meet stringent quality and regulatory standards. His professional journey includes significant roles at major pharmaceutical companies such as GSK, Pfizer, and MedImmune, where he honed his skills in commercial product development and gene therapy.